Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 1
2002 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 4
2012 6
2013 12
2014 15
2015 20
2016 20
2017 19
2018 14
2019 11
2020 17
2021 12
2022 11
2023 21
2024 18
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Current challenges in HER2-positive breast cancer.
Puglisi F, Fontanella C, Amoroso V, Bianchi GV, Bisagni G, Falci C, Fontana A, Generali D, Gianni L, Grassadonia A, Moscetti L, Portarena I, Rossi E, Marchetti P. Puglisi F, et al. Among authors: fontanella c. Crit Rev Oncol Hematol. 2016 Feb;98:211-21. doi: 10.1016/j.critrevonc.2015.10.016. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26638862 Free article. Review.
Ramucirumab: preclinical research and clinical development.
Aprile G, Rijavec E, Fontanella C, Rihawi K, Grossi F. Aprile G, et al. Among authors: fontanella c. Onco Targets Ther. 2014 Oct 29;7:1997-2006. doi: 10.2147/OTT.S61132. eCollection 2014. Onco Targets Ther. 2014. PMID: 25378934 Free PMC article. Review.
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Fontanella C, Giorgi CA, Russo S, Angelini S, Nicolardi L, Giarratano T, Frezzini S, Pestrin M, Palleschi D, Bolzonello S, Parolin V, Haspinger ER, De Rossi C, Greco F, Gerratana L. Fontanella C, et al. Crit Rev Oncol Hematol. 2022 Dec;180:103848. doi: 10.1016/j.critrevonc.2022.103848. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257536 Free article. Review.
Clinical advances in the development of novel VEGFR2 inhibitors.
Fontanella C, Ongaro E, Bolzonello S, Guardascione M, Fasola G, Aprile G. Fontanella C, et al. Ann Transl Med. 2014 Dec;2(12):123. doi: 10.3978/j.issn.2305-5839.2014.08.14. Ann Transl Med. 2014. PMID: 25568876 Free PMC article. Review.
191 results